EYLEA

Bayer Inc🇨🇦 Health Canada

Approval Id: 5dbc112c17548b1f
Drug Approval Canada Name: EYLEA
Product Name: EYLEA
Status: Marketed
Status Date: 2020-11-17
Original Market Date: 2020-11-17
Din: 02505355
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravitreal
Schedule: Prescription , Schedule D
Ahfs: 52:92.00
Atc Original: S01LA05 AFLIBERCEPT
Atc Name: s 01 la 05
Aig Number: 0154950001
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

AFLIBERCEPT

2 MG / 0.05 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5dbc112c17548b1f

Type

Standard